< Back to Jobs

Life Sciences Associate - Senior Associate

Frazier Healthcare Partners

Menlo Park, CA

Posted September 27

Job Description

The Frazier Life Sciences team is looking for an exceptional individual to join our team based in Menlo Park, CA. We invest across the spectrum of biopharmaceutical opportunities (company formation through public companies), and are looking for an Associate or Senior Associate to work on all aspects of our deals, including identification of companies to invest in or assets to form new companies around, technical due diligence, creation of business plans / investment angles, and term sheet preparation and negotiation. We are a small and entrepreneurial team and are looking for an individual who can slot seamlessly into our fast-paced culture.

Frazier Life Sciences is committed to diversity and inclusion and we strongly encourage minority candidates to apply. Essential characteristics of the individual we seek include:

Please provide brief responses to the following three questions:

  1. What is one area of science or drug development that excites you?
  2. What is an example from your career where your contribution has had meaningful impact?
  3. What is one activity / interest that you are passionate about outside of work?

About Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a leading provider of venture and growth capital to healthcare companies. The firm has over $4.8 billion under management, with the Life Sciences team currently investing out of a $617 million Life Sciences-focused fund raised at the beginning of 2020. Frazier Life Sciences investments span the development and commercialization spectrum, from preclinical drug discovery companies all the way through cash-flow positive companies. Company creation has been a core element of Frazier’s investment strategy, and the firm’s 29-year history has helped to build an exceptional network of successful entrepreneurs and advisors to start-up, operate, and advise transformative Life Sciences companies. Frazier Life Sciences portfolio companies have been involved in M&A and IPO transactions worth over $20 billion in the past 10 years, and more importantly, have been the source of over 29 FDA approved drugs since 2010 in oncology, anti-infectives, cardiovascular disease, and other areas.

Invite Friends To Join Doc